Skip to main content

Table 2 Comparison of discharge status: dropout or completed by patient characteristics

From: Substance use disorder treatment retention and completion: a prospective study of horse-assisted therapy (HAT) for young adults

Variable Item Dropout Completed Total % Chi square
N = 65 N = 43 N = 108 100
Participation in HAT No 37 (56.9) 6 (14.0) 43 39.8 19.94, p < 0.001
Yes 28 (43.1) 37 (86.0) 65 60.2
Days in treatment
 Mean <113 days 50 (76.9) 10 (23.3) 60 55.6 30.18, p < 0.001
113+ days 15 (23.1) 33 (76.7) 48 44.4
 Critical period <90 days 44 (67.7) 5 (11.6) 49 45.4 32.82, p < 0.001
90+ days 21 (32.3) 38 (88.4) 59 54.6
Gender Female 16 (24.6) 14 (32.6) 30 27.8 0.81, p = 0.367
Male 49 (75.4) 29 (67.4) 78 72.2
Age <20 years 12 (18.5) 2 (4.7) 14 13 4.81, p = 0.090
20–26 years 43 (66.2) 31 (72.3) 74 68.5
27+ years 10 (15.4) 10 (23.3) 20 18.5
Years of schooling <10 years 13 (20.0) 5 (11.6) 18 16.7 1.96, p = 0.376
10–12 years 42 (64.6) 28 (65.1) 70 64.8
13+ years 10 (15.4) 10 (23.3) 20 18.5
Primary substance Cannabis 23 (35.4) 19 (44.2) 42 38.9 4.75, p = 0.577
Alchol 14 (21.5) 6 (14.0) 20 18.5
Heroin 12 (18.5) 5 (11.6) 17 15.7
Amphetamine 7 (10.8) 8 (18.6) 15 13.9
Benzodiazepine 5 (7.7) 3 (7.0) 8 7.4
GHBa 2 (3.1) 2 (4.7) 4 3.7
Cocaine 2 (3.1) 0 (0.0) 2 1.9
No. of substances 1 substances 20 (30.8) 15 (34.9) 35 32.4 0.15, p = 0.292
2 substances 16 (24.6) 15 (34.9) 31 28.7
3 substances 29 (44.6) 13 (30.2) 42 38.9
Age of first use <16 years 35 (53.8) 22 (51.2) 57 52.8 0.08, p = 0.785
16+ years 30 (46.2) 21 (48.8) 51 47.2
Substitution medicineb No 55 (84.6) 37 (86.0) 92 85.2 0.42, p = 0.840
Yes 10 (15.4) 6 (14.0) 16 14.8
HSCL-25c <1.75 12 (18.5) 7 (16.3) 19 17.6 0.09, p = 0.771
1.75+ 53 (81.5) 36 (83.7) 89 82.4
Psych co-morbidity (at entry) None diagnosed 32 (49.2) 26 (60.5) 58 53.7 2.25, p = 0.325
1 diagnosed 24 (36.9) 10 (23.3) 34 31.5
2+ diagnosed 9 (13.8) 7 (16.3) 16 14.8
Temporary exit No exit 42 (64.6) 23 (53.5) 65 60.2 1.87, p = 0.393
1 re-entry 14 (21.5) 10 (23.3) 24 22.3
2+ re-entries 9 (13.8) 10 (23.3) 19 17.6
  1. aGamma hydroxybutyrate (C4H8O3)
  2. bOpioid pharmacotherapy
  3. cHopkins Symptom Checklist-25